Fecha registrada: March 19 2014

Duration: 51 minutes 30 seconds

The end point of any particle size measurement is to provide improved product or process understanding and/or control. It order to achieve this, it is important that the size specifications selected are relevant to those products or processes. In this webinar, we will look at the size distribution data generated by technqiues such as laser diffraction and image analysis, and will consider how these can be used to generate realistic product specifications.
Table of contents
1. Setting pharmaceutical product specifications for particle size analysis
00:55
2. Setting pharmaceutical product specifications for particle size analysis
01:22
3. What should be the first stage in setting a specification?
01:19
4. The first stage in QbD is definition of the target product profile and its associated quality attributes
01:18
5. When should particle size be considered as a critical quality attribute?
00:59
6. Where should I measure my product?
01:54
7. When should I measure my product?
02:23
8. What product form is most relevant?
02:01
9. Dissolution dynamics: what should I measure?
01:32
10. Content uniformity: what should I measure?
01:21
11. Dispersion stability: what should I measure?
02:14
12. Suspension properties : what should I measure?
00:52
13. Case study: setting specifications for solid dosage forms
01:07
14. Selecting appropriate control parameters
03:06
15. Setting specification tolerances
00:05
16. Controlling the dispersion properties of powders
01:25
17. Controlling the dispersion properties of powders
01:51
18. Optimising atomisation processes
01:40
19. Optimising atomisation processes
01:10
20. Optimising atomisation processes
00:54
21. Optimising atomisation processes
01:41
22. Setting specifications for specific components within pharmaceutical blends
01:57
23. Setting specifications for specific components within pharmaceutical blends
01:01
24. Linking measurements specifications and product manufacturing specification
01:27
25. Setting specifications: tablets
01:23
26. Conclusions
01:19
27. Contact Information
13:14